Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion

Open access

Abstract

Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD+) synthesis, and Sirt1, an NAD+-dependent histone deacetylase, protect the heart against ischemia/reperfusion (I/R). It remains unknown whether Nampt mediates the protective effect of ischemic preconditioning (IPC), whether nicotinamide mononucleotide (NMN, 500 mg/kg), a product of Nampt in the NAD+ salvage pathway, mimics the effect of IPC, or whether caloric restriction (CR) upregulates Nampt and protects the heart through a Sirt1-dependent mechanism. IPC upregulated Nampt protein, and the protective effect of IPC against ischemia (30 minutes) and reperfusion (24 hours) was attenuated at both early and late phases in Nampt +/- mice, suggesting that Nampt plays an essential role in mediating the protective effect of IPC. In order to mimic the effect of Nampt, NMN was administered by intraperitoneal injection. NMN significantly increased the level of NAD+ in the heart at baseline and prevented a decrease in NAD+ during ischemia. NMN protected the heart from I/R injury when it was applied once 30 minutes before ischemia or 4 times just before and during reperfusion, suggesting that exogenous NMN protects the heart from I/R injury in both ischemic and reperfusion phases. The protective effect of NMN was accompanied by decreases in acetylation of FoxO1, but it was not obvious in Sirt1 KO mice, suggesting that the effect of NMN is mediated through activation of Sirt1. Compared to control diet (90% calories), CR (60% calories for 6 weeks) in mice led to a significant reduction in I/R injury, accompanied by upregulation of Nampt. The protective effect of CR against I/R injury was not significant in cardiac-specific Sirt1 KO mice, suggesting that the protective effect of CR is in part mediated through the Nampt-Sirt1 pathway. In conclusion, exogenous application of NMN and CR protects the heart by both mimicking IPC and activating Sirt1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0098972

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Nampt expression is upregulated by ischemic preconditioning (IPC). A, The IPC protocol for wild-type mice. Mice on C57BL/6 background were subjected to 6 cycles of 3 minutes of ischemia plus 3 minutes of reperfusion. Sham groups were subjected to open chest surgery only. Arrows indicate the timing of biochemical analyses. B, Nampt mRNA expression 8 hours and 24 hours after IPC was determined by quantitative RT-PCR. n = 4. C, Nampt protein expression 20 minutes and 24 hours after IPC was determined by Western blot. D, Nampt protein expression with or without IPC in Nampt +/− mice and their wild-type littermates. E-G, Nampt +/− and littermate wild-type mice were subjected to IPC as shown in A. Five minutes or 24 hours after IPC, the mice were subjected to ischemia (30 minutes)/reperfusion (24 hours) (I/R). Some mice were subjected to I/R without IPC. Infarct size/AAR (E), AAR (F) and % reduction in infarct size compared to those without IPC (G) are shown. In E and F, ## p<0.01 vs. wild-type littermates subjected to the same surgery. n = 4 to 8. In G, ## p<0.01 vs. wild-type littermates subjected to I/R 5 minutes after IPC. In B, E, F and G, n.s., not significant; * p<0.05, ** p<0.01.
Figure 1 Nampt expression is upregulated by ischemic preconditioning (IPC). A, The IPC protocol for wild-type mice. Mice on C57BL/6 background were subjected to 6 cycles of 3 minutes of ischemia plus 3 minutes of reperfusion. Sham groups were subjected to open chest surgery only. Arrows indicate the timing of biochemical analyses. B, Nampt mRNA expression 8 hours and 24 hours after IPC was determined by quantitative RT-PCR. n = 4. C, Nampt protein expression 20 minutes and 24 hours after IPC was determined by Western blot. D, Nampt protein expression with or without IPC in Nampt +/− mice and their wild-type littermates. E-G, Nampt +/− and littermate wild-type mice were subjected to IPC as shown in A. Five minutes or 24 hours after IPC, the mice were subjected to ischemia (30 minutes)/reperfusion (24 hours) (I/R). Some mice were subjected to I/R without IPC. Infarct size/AAR (E), AAR (F) and % reduction in infarct size compared to those without IPC (G) are shown. In E and F, ## p<0.01 vs. wild-type littermates subjected to the same surgery. n = 4 to 8. In G, ## p<0.01 vs. wild-type littermates subjected to I/R 5 minutes after IPC. In B, E, F and G, n.s., not significant; * p<0.05, ** p<0.01.CC BY · PubMed Central
Figure 2 NAD+ content in the heart is reduced in Nampt +/− mice. A and B, Heart homogenates were prepared from Nampt +/− mice and their wild-type (Wt) littermates. A, NAD+ and NADH contents. B, NAD+/NADH ratio. C-E, Mice were subjected to sham procedure or IPC, as shown in Figure 1A. Mice were then subjected to either 30 minutes ischemia or sham operation 5 minutes after the sham procedure or either 5 minutes or 24 hours after IPC. C, NAD+ contents. D, NADH contents. E, NAD+/NADH ratio. In A-E, n = 4. n.s., not significant; * p<0.05, ** p<0.01.
Figure 2 NAD+ content in the heart is reduced in Nampt +/− mice. A and B, Heart homogenates were prepared from Nampt +/− mice and their wild-type (Wt) littermates. A, NAD+ and NADH contents. B, NAD+/NADH ratio. C-E, Mice were subjected to sham procedure or IPC, as shown in Figure 1A. Mice were then subjected to either 30 minutes ischemia or sham operation 5 minutes after the sham procedure or either 5 minutes or 24 hours after IPC. C, NAD+ contents. D, NADH contents. E, NAD+/NADH ratio. In A-E, n = 4. n.s., not significant; * p<0.05, ** p<0.01.CC BY · PubMed Central
Figure 3 NAD+ content after NMN administration. A-C, NMN (500 mg/kg) or vehicle (phosphate buffered saline) was administered to mice and the hearts were harvested at the indicated time points. n = 3 to 4. A, NAD+ contents. B, NADH contents. C, NAD+/NADH ratio. D, The protocol for NMN injection followed by 30 minutes ischemia for the measurement of NAD+, NADH and NAD+/NADH in E-G. E, NAD+ contents. F, NADH contents. G, NAD+/NADH ratio. In E-G, n = 4. In A-C and E-G, n.s., not significant, * p<0.05, ** p<0.01.
Figure 3 NAD+ content after NMN administration. A-C, NMN (500 mg/kg) or vehicle (phosphate buffered saline) was administered to mice and the hearts were harvested at the indicated time points. n = 3 to 4. A, NAD+ contents. B, NADH contents. C, NAD+/NADH ratio. D, The protocol for NMN injection followed by 30 minutes ischemia for the measurement of NAD+, NADH and NAD+/NADH in E-G. E, NAD+ contents. F, NADH contents. G, NAD+/NADH ratio. In E-G, n = 4. In A-C and E-G, n.s., not significant, * p<0.05, ** p<0.01.CC BY · PubMed Central
Figure 4 NMN administration reduces I/R injury. Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to mice according to one of four different protocols (Figure S4 in File S1), the mice were subjected to I/R, and the extent of I/R injury was evaluated with TTC staining. In A-H, control mice were used. NMN or PBS was injected once 12 hours before I/R (A and B), once 30 minutes before I/R (C and D), once just before reperfusion (E and F) or once just before reperfusion and 3 more times every 6 hours thereafter (G and H). In I and J, NMN or PBS was injected once 30 minutes before I/R in Nampt+/− mice. Infarct area/AAR (A, C, E, G, and I) and AAR (B, D, F, H, and J) are shown. n = 4 to 7. n.s., not significant; * p<0.05, ** p<0.01.
Figure 4 NMN administration reduces I/R injury. Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to mice according to one of four different protocols (Figure S4 in File S1), the mice were subjected to I/R, and the extent of I/R injury was evaluated with TTC staining. In A-H, control mice were used. NMN or PBS was injected once 12 hours before I/R (A and B), once 30 minutes before I/R (C and D), once just before reperfusion (E and F) or once just before reperfusion and 3 more times every 6 hours thereafter (G and H). In I and J, NMN or PBS was injected once 30 minutes before I/R in Nampt+/− mice. Infarct area/AAR (A, C, E, G, and I) and AAR (B, D, F, H, and J) are shown. n = 4 to 7. n.s., not significant; * p<0.05, ** p<0.01.CC BY · PubMed Central
Figure 5 The cardioprotective effect of NMN depends on Sirt1 expression. A, Acetylation levels of FoxO1 after 30 minutes of ischemia or sham operation with or without NMN administration. n = 4. n.s., not significant; # p<0.05, ## p<0.01 vs. respective sham-operated group. B and C, Either NMN (500 mg/kg) or vehicle (PBS) was administered (i.p. injection) to control or cardiac-specific Sirt1 knockout (Sirt1KO) mice 30 minutes before subjecting the mice to 30 minutes of ischemia followed by 24 hours of reperfusion (I/R). The extent of infarction was evaluated with TTC staining. Infarct area/AAR (B) and AAR (C) are shown. n = 4 to 5. n.s., not significant; * p<0.05, ## p<0.01 vs. respective control mice group. D, Schematic model of the protective effect of NMN against I/R injury. IPC: ischemic preconditioning; CR: caloric restriction; NMN: nicotinamide mononucleotide; NAD: nicotinamide adenine dinucleotide; I/R: ischemia/reperfusion.
Figure 5 The cardioprotective effect of NMN depends on Sirt1 expression. A, Acetylation levels of FoxO1 after 30 minutes of ischemia or sham operation with or without NMN administration. n = 4. n.s., not significant; # p<0.05, ## p<0.01 vs. respective sham-operated group. B and C, Either NMN (500 mg/kg) or vehicle (PBS) was administered (i.p. injection) to control or cardiac-specific Sirt1 knockout (Sirt1KO) mice 30 minutes before subjecting the mice to 30 minutes of ischemia followed by 24 hours of reperfusion (I/R). The extent of infarction was evaluated with TTC staining. Infarct area/AAR (B) and AAR (C) are shown. n = 4 to 5. n.s., not significant; * p<0.05, ## p<0.01 vs. respective control mice group. D, Schematic model of the protective effect of NMN against I/R injury. IPC: ischemic preconditioning; CR: caloric restriction; NMN: nicotinamide mononucleotide; NAD: nicotinamide adenine dinucleotide; I/R: ischemia/reperfusion.CC BY · PubMed Central
Figure 6 The cardioprotective effect of caloric restriction depends on Sirt1 expression. Control mice (Cre(-) Sirt1flox/flox) or cardiac-specific Sirt1 heterozygous (Cre(+): Sirt1flox/+) or homozygous (Cre(+): Sirt1flox/flox) KO mice were subjected to either caloric restriction (CR) or normal diet (ND) feeding for 6 weeks and then subjected to 30 minutes of ischemia followed by 24 hours of reperfusion (I/R). A, Time course of the body weight (g) of the mice. Before the mice were subjected to CR or ND, their eating behavior was closely observed for 14 days (running period). n = 4 to 10. B, The abundance of Nampt mRNA after 6 weeks of CR or ND was evaluated with qPCR. n = 4 to 5. * p<0.05. C and D, Infarct area/AAR (C) and AAR (D) were evaluated with injection of Alcian Blue dye and TTC staining. n = 3 to 6. n.s., not significant; * p<0.05, # p<0.05 vs. Cre(-) ND group, ## p<0.01 vs. Cre(-) ND group, †† p<0.01 vs. Cre(-) CR group.
Figure 6 The cardioprotective effect of caloric restriction depends on Sirt1 expression. Control mice (Cre(-) Sirt1flox/flox) or cardiac-specific Sirt1 heterozygous (Cre(+): Sirt1flox/+) or homozygous (Cre(+): Sirt1flox/flox) KO mice were subjected to either caloric restriction (CR) or normal diet (ND) feeding for 6 weeks and then subjected to 30 minutes of ischemia followed by 24 hours of reperfusion (I/R). A, Time course of the body weight (g) of the mice. Before the mice were subjected to CR or ND, their eating behavior was closely observed for 14 days (running period). n = 4 to 10. B, The abundance of Nampt mRNA after 6 weeks of CR or ND was evaluated with qPCR. n = 4 to 5. * p<0.05. C and D, Infarct area/AAR (C) and AAR (D) were evaluated with injection of Alcian Blue dye and TTC staining. n = 3 to 6. n.s., not significant; * p<0.05, # p<0.05 vs. Cre(-) ND group, ## p<0.01 vs. Cre(-) ND group, †† p<0.01 vs. Cre(-) CR group.CC BY · PubMed Central
Figure 7 NMN stimulates autophagy in control hearts. A, Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to Tg-mRFP-GFP-LC3 mice. After 2 hours, the number of fluorescent LC3 dots was evaluated. Representative images of GFP puncta, mRFP puncta and their merged images are shown. The results of the quantitative analysis of RFP only dots and RFP/GFP double positive (yellow) dots/area are also shown. B, Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to mice 30 minutes before I/R, and then the mice were subjected to either 30 minutes ischemia followed by 24 hours of reperfusion or sham operation. The extent of cardiomyocyte apoptosis in the border zone was evaluated with TUNEL staining. The results of the quantitative analysis of TUNEL-positive cardiomyocytes are shown. C. Three days after isolation, cardiomyocytes were treated with the indicated dosage of NMN for 30 minutes (Left) and with 1000 nM NMN for the indicated time (Right). ATP contents were measured by ATP Bioluminescent Assay Kit (Sigma). n = 4 (Left) and 3(Right).
Figure 7 NMN stimulates autophagy in control hearts. A, Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to Tg-mRFP-GFP-LC3 mice. After 2 hours, the number of fluorescent LC3 dots was evaluated. Representative images of GFP puncta, mRFP puncta and their merged images are shown. The results of the quantitative analysis of RFP only dots and RFP/GFP double positive (yellow) dots/area are also shown. B, Either NMN (500 mg/kg per injection) or vehicle (PBS) was administered (i.p. injection) to mice 30 minutes before I/R, and then the mice were subjected to either 30 minutes ischemia followed by 24 hours of reperfusion or sham operation. The extent of cardiomyocyte apoptosis in the border zone was evaluated with TUNEL staining. The results of the quantitative analysis of TUNEL-positive cardiomyocytes are shown. C. Three days after isolation, cardiomyocytes were treated with the indicated dosage of NMN for 30 minutes (Left) and with 1000 nM NMN for the indicated time (Right). ATP contents were measured by ATP Bioluminescent Assay Kit (Sigma). n = 4 (Left) and 3(Right).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 315

Metadata

Authors
Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J.
Affiliations
Rutgers New Jersey Medical School (US)
Corresponding author
Sadoshima, Junichi
Venue
PLoS ONE
Published
2014-06-06
Volume
9
Issue
6
Pages
e98972
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2163282809
Cited by
305
References
29
Citations by year
2026: 17 · 2025: 21 · 2024: 29 · 2023: 32 · 2022: 30 · 2021: 34 · 2020: 34 · 2019: 18 · 2018: 29 · 2017: 20 · 2016: 24 · 2015: 16 · 2014: 1
FWCI
15.12
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fondation Leducq (HL69020, HL67724, AG27211, HL91469, HL102738)
  • U.S. Public Health Service (HL91469, AG27211, HL67724, HL69020, HL102738, HL59139)
  • National Institute on Aging (P01AG027211, R01AG023039, AG27211)
  • National Heart, Lung, and Blood Institute (HL59139, HL91469, R01HL067724, HL69020, HL102738, R01HL102738, R01HL112330, HL-67724, P01HL059139, P01HL069020, R01HL091469)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
nicotinamide mononucleotide, NAD+ salvage pathway, visfatin, SIRT1, ischemia-reperfusion injury, myocardial ischemia, ischemic preconditioning, caloric restriction, cardioprotection, NAD+ depletion
MeSH terms
Animals, Cardiotonic Agents, Heart, Male, Myocardial Infarction, NAD, Nicotinamide Mononucleotide, Reperfusion Injury, Up-Regulation, Myocardial Ischemia, Ischemic Preconditioning, Caloric Restriction, Mice, Nicotinamide Phosphoribosyltransferase, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion. https://app.cochat.ai/papers/10.1371/journal.pone.0098972
The paper
Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J. (2014). Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion. PLoS ONE. https://doi.org/10.1371/journal.pone.0098972

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.